BIOPHARMACEUTICAL INNOVATORS ARE LEADING THE CHARGE IN FIGHT AGAINST CORONAVIRUS
As the threat of the novel coronavirus continues to grow globally, innovative biopharmaceutical companies are ramping up efforts to study the
virus and develop vaccines and antivirals.
BIO member companies are working closely with U.S. government agencies, Chinese authorities, non-governmental entities
and the World Health Organization to identify their most pressing needs in the areas of vaccination, diagnostics, antivirals, and other
treatments, and to facilitate collaborations with industry.
See a snapshot of how our industry – comprised of both large and small innovators – is responding: